Newsroom

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS) (“GeneDx” or the “Company”), if they purchased or otherwise acquired the Company’s shares between April 16, 2025 and May 4, 2026, inclusive (the “Clas...

OSAKA, Giappone--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) oggi ha annunciato che il lancio di Resident Evil Veronica, l'ultimo titolo nella serie Resident Evil, è previsto per il 2027. La saga Resident Evil comprende giochi di sopravvivenza in contesti di orrore, nei quali i giocatori si servono di una varietà di armi e altri oggetti per sopravvivere in situazioni terrificanti. Grazie a una base di appassionati giocatori a livello globale, le vendite complessive dei giochi fin dal primo t...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) securities during the period of February 24, 2026 through May 26, 2026, inclusive (“the Class Period”).If you suffered a loss on your Verra Mobility investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff ap...

SYDNEY--(BUSINESS WIRE)--Grafana Labs, the company behind the open observability cloud, today announced that PointsBet, one of Australia’s fastest-growing digital wagering operators, has selected Grafana Cloud as its unified observability platform. PointsBet is using Grafana Cloud to consolidate telemetry across its proprietary betting platform, accelerate incident resolution with AI-powered insights, and give engineering teams the visibility they need to own and operate their services with con...

NEW ORLEANS--(BUSINESS WIRE)--Posterpräsentation von Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P im Rahmen der 86. ADA-Wissenschaftstagung in New Orleans, in der erste Daten aus Humanstudien zu Oraglutide™ vorgestellt wurden — einem in kleinen Kapseln verabreichten, im Darm freigesetzten oralen Semaglutid, das unter Verwendung der firmeneigenen Axcess™-Verabreichungstechnologie entwickelt wurde. DIE WICHTIGSTEN HIGHLIGHTS 6-Tage-Glukosekontrolle: Eine einmalige or...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired PicS N.V. (“PicS” or the “Company”) (NASDAQ:PICS) securities during the period from January 27, 2026 through June 5, 2026. If you suffered a loss on your PicS investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. If you choose to take no...

OSAKA, Japón--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) anunció hoy que Resident Evil Veronica, el juego más reciente de la serie Resident Evil, tiene fecha de lanzamiento prevista para 2027. La franquicia Resident Evil incluye juegos de terror de supervivencia donde los jugadores utilizan una serie de armas y otros objetos para sobrevivir en situaciones aterradoras. Con el apoyo de una base de fanáticos global apasionada, las ventas de juegos totales desde el primer lanzamiento de esta se...

NOUVELLE-ORLÉANS--(BUSINESS WIRE)--Présentation par affiche de Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P lors de la 86e session scientifique de l’ADA, à La Nouvelle-Orléans, rendant compte des premières données humaines sur l’Oraglutide™, une petite capsule de séma-glutide oral à libération intestinale, formulée à l’aide de la technologie de délivrance exclusive Axcess™. POINTS CLÉS Contrôle glycémique sur 6 jours : une dose orale unique de 4 mg d’Oraglutide™ a...

SAN FRANCISCO--(BUSINESS WIRE)--ClickHouse, a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced a significant expansion of its global go-to-market (GTM) leadership team, headlined by the appointment of Ed Lenta as Vice President, Asia Pacific and Japan (APJ). The additions build on the momentum established last year with the appointment of Kevin Egan as Chief Revenue Officer, and reflect ClickHouse's strategic investment in scaling its global organizatio...

紐奧良--(BUSINESS WIRE)--(美國商業資訊)-- Diabetology Limited (Jersey) 在紐奧良舉行的第86屆美國糖尿病協會（ADA）科學年會上，以海報演說會形式（https://diabetology.co.uk/ada-poster ) 1724-P展示了Oraglutide™的首批人體資料。Oraglutide™是一種小膠囊腸道釋放型口服索馬魯肽，採用專有的Axcess™遞送技術配製而成。 主要亮點 6天血糖控制：單次口服4毫克Oraglutide™即可達到血糖持續下降。在第6天測得14%的療效（p=0.046），這是在人體靜脈葡萄糖耐受試驗（IVGTT）研究中，單次口服GLP-1給藥後持續時間最長的療效。 胰島素分泌增加28%：與安慰劑相比，胰島素AUC百分比在第0天增加12%（p=0.02），第1天增加28%（p=0.025）。 新型腸道緩釋作用：第1天的索馬魯肽血中濃度高於第0天，與腸壁脂質相關的緩釋作用一致，是一項全新的藥理學發現。 未觀察到噁心或副作用：在為期一周的8名受試者群組中，未觀察到任何不良反應，這與針對迷走神經傳入機制進行治...